Dr. Pepper-Snapple strengthens product development with Infor Optiva
Bob Wimpfheimer, senior manager of R&D at Dr. Pepper Snapple Group, discusses the value of Infor Optiva to his organization. To meet new US Food & Drug Administration labeling requirements, the group consolidated its processes into Infor Optiva. The result: label output creation time cut in half, and error rate reduced at least 90%. The group also has expanded its use of Optiva to procurement and quality management.